About
Cartesian Therapeutics is a clinical-stage biotechnology company developing mRNA-based cell therapies for the treatment of autoimmune diseases.
Explore Cartesian Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.